Mouse Models of Cancer Study
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Relative Risk
Hypertension III: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 20, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
Adam R Brentnall1, Wendy F Cohn2, William A Knaus3
1Queen Mary University of London, Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, London, UK.
Accurate breast cancer risk assessment is improved by combining mammographic density measures with the Tyrer-Cuzick model. This enhances risk stratification for personalized screening and prevention strategies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: